Cytodyn Inc (CYDY)

[woodenbear]

Not exactly true Fred. In contrast to the blind combo trial, the mono is open labeled as blackdoggie has reported on many times. It also has over 100 people enrolled. So when combo results come out, a potential big pharma company buyer can sign an NDA and have access to the ongoing results of mono. I'm thinking mono enrollment will close by year end and there will be plenty of indications of how things are going. If things are going well there wil be pressure to buy prior to the end of the trial in order not to get scooped by competition.

But you are right. If combo results are bad or just ok. That will hurt SP in short term and probably prolong any potential buyout. Meaning dilution to some extent will be necessary. I could be mistaken but hasn't management already given us an amount needed to complete both trials and it wasn't an extraordinary amount? As I have said before if you are in this game and afraid of some dilution, you are in the wrong game. The real dilution will come if CYDY tries to take to market. But management has indicated they do not wish to take to market alone. Meaning they will sell at a certain price if the drug works.